Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1371/journal.pone.0021226 http://scihub22266oqcxt.onion/10.1371/journal.pone.0021226 21738623!3124487!21738623     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       PLoS+One 2011 ; 6 (6): e21226 Nephropedia Template TP {{tp|p=21738623|t=2011. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes |pdf=|usr=}}{{21738623}} gab.com Text Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes JO: PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=21738623 #FOAvip The elevated glycation of macromolecules by the reactive dicarbonyl and alpha-oxoaldehyde methylglyoxal (MG) has been associated with diabetes and its complications. We have identified a rare flavone, fisetin, which increases the level and activity of glyoxalase 1, the enzyme required for the removal of MG, as well as the synthesis of its essential co-factor, glutathione. It is shown that fisetin reduces two major complications of diabetes in Akita mice, a model of type 1 diabetes. Although fisetin had no effect on the elevation of blood sugar, it reduced kidney hypertrophy and albuminuria and maintained normal levels of locomotion in the open field test. This correlated with a reduction in proteins glycated by MG in the blood, kidney and brain of fisetin-treated animals along with an increase in glyoxalase 1 enzyme activity and an elevation in the expression of the rate-limiting enzyme for the synthesis of glutathione, a co-factor for glyoxalase 1. The expression of the receptor for advanced glycation end products (RAGE), serum amyloid A and serum C-reactive protein, markers of protein oxidation, glycation and inflammation, were also increased in diabetic Akita mice and reduced by fisetin. It is concluded that fisetin lowers the elevation of MG-protein glycation that is associated with diabetes and ameliorates multiple complications of the disease. Therefore, fisetin or a synthetic derivative may have potential therapeutic use for the treatment of diabetic complications. Twit Text FOAVip Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes ????PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=21738623 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=21738623 #FOAvip English Wikipedia <ref>{{Cite pmid|21738623}}</ref> Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes #MMPMID21738623 Maher P; Dargusch R; Ehren JL; Okada S; Sharma K; Schubert D PLoS One 2011[]; 6 (6): e21226 PMID21738623show ga The elevated glycation of macromolecules by the reactive dicarbonyl and alpha-oxoaldehyde methylglyoxal (MG) has been associated with diabetes and its complications. We have identified a rare flavone, fisetin, which increases the level and activity of glyoxalase 1, the enzyme required for the removal of MG, as well as the synthesis of its essential co-factor, glutathione. It is shown that fisetin reduces two major complications of diabetes in Akita mice, a model of type 1 diabetes. Although fisetin had no effect on the elevation of blood sugar, it reduced kidney hypertrophy and albuminuria and maintained normal levels of locomotion in the open field test. This correlated with a reduction in proteins glycated by MG in the blood, kidney and brain of fisetin-treated animals along with an increase in glyoxalase 1 enzyme activity and an elevation in the expression of the rate-limiting enzyme for the synthesis of glutathione, a co-factor for glyoxalase 1. The expression of the receptor for advanced glycation end products (RAGE), serum amyloid A and serum C-reactive protein, markers of protein oxidation, glycation and inflammation, were also increased in diabetic Akita mice and reduced by fisetin. It is concluded that fisetin lowers the elevation of MG-protein glycation that is associated with diabetes and ameliorates multiple complications of the disease. Therefore, fisetin or a synthetic derivative may have potential therapeutic use for the treatment of diabetic complications. |Animals[MESH] |Anxiety/drug therapy[MESH] |Cell Line[MESH] |Diabetes Complications/*prevention & control[MESH] |Diabetes Mellitus/*drug therapy/metabolism[MESH] |Flavonoids/*therapeutic use[MESH] |Flavonols[MESH] |Glycosylation/*drug effects[MESH] |Mice[MESH] |Mice, Inbred C57BL[MESH] |Pyruvaldehyde/*metabolism[MESH] |Receptor for Advanced Glycation End Products[MESH] |Receptors, Immunologic/metabolism[MESH]Fisetin lowers methylglyoxal dependent protein glycation and limits th(epmc).pdf DeepDyve Pubget Overpricing